Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma

Published 2012 View Full Article

Authors

Keywords

Src, Melanoma, AZD0530, Clinical trials, IL-2

Journal

INVESTIGATIONAL NEW DRUGS

Volume 31, Issue 3, Pages 769-773

Publisher

Springer Nature

Online

2012-11-14

DOI

10.1007/s10637-012-9897-4

References

View 7 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now